Timing of anti-PD-L1 antibody initiation affects efficacy/toxicity of CD19 CAR T-cell therapy for large B-cell lymphoma.
Blood Adv
; 8(2): 453-467, 2024 01 23.
Article
in En
| MEDLINE
| ID: mdl-37903325
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Immunotherapy, Adoptive
/
Lymphoma, Large B-Cell, Diffuse
Limits:
Adult
/
Humans
Language:
En
Journal:
Blood Adv
Year:
2024
Document type:
Article